Hans-Gustaf Ljunggren - Curriculum Vitae#

Academic degrees and positions

• 1984 Bachelor of Medicine, KI
  
• 1990 Ph.D., Karolinska Institutet (KI)
  
• 1990 Assist. professor, KI
  
• 1992 M.D., KI
  
• 1996 Associate Professor, KI
  
• 2001 Full Professor
  

Commissions of trust - academic, research foundations, societies, and philanthropy

• 1985 President, Medical Student Association, KI
  
• 1998 - 2003 Scientific Secretary, Swedish Cancer Society
  
• 2000 - 2002 Chairman, Steering Committee for Research Financing Organizations in Sweden
  
• 2005 - 2011 Board of Research (faculty representative), KI
  
• 2006 - 2007 Strategy Group Life Sciences, Swedish Foundation Strategic Research
  
• 2008 - 2011 Vice President, Society for Natural Immunity (SNI), AAI
  
• 2008 - 2013 Vice Chairman, Department of Medicine, KI
  
• 2008 Member, the Nobel Assembly of Karolinska Institutet, KI
  
• 2010 Ambassador, Stockholm-Uppsala Life Sciences Organization
  
• 2011 Board Scandinavian Foundation for Immunology
  
• 2011 - 2013 Board (faculty representative), KI
  
• 2012 - 2015 President, Society for Natural Immunity (SNI), AAI
  
• 2008 - 2013 Board, Stockholm County Council Research Committee
  
• 2013 Member, Åke Olsson Foundation
  
• 2013 - 2016 Chairman, Stockholm County Council Research Committee
  
• 2013 - 2016 Dean of Research, KI
  
• 2013 - 2016 Board, Gustaf och Tyra Svensson’s Foundation
  
• 2013 - 2016 Board, David och Astrid Hagelen’s Foundation
  
• 2013 - 2016 Board, Erik and Edith Fernström’s Foundation
  
• 2013 - 2016 Board, Hagbergska Foundation
  
• 2013 - 2016 Chairman, Board Gunnel and Svante Högbom Foundation
  
• 2013 - 2016 Chariman, Cederberg Foundation
  
• 2013 - 2016 Chairman, Eric K Fernström Prize Committee
  
• 2013 - 2016 Board, Stockholm County Council-KI Organization
  
• 2013 - 2016 Board, Science for Life Laboratories (SciLifeLab)
  
• 2015 - 2019 Board, Mats Sundin Foundation
  
• 2016 - 2018 Past President, Society for Natural Immunity (SNI), AAI
  
• 2017 - 2019 Affiliated Dean, Nova Southeastern Univ., Ft Lauderdale, FL, USA
  
• 2020 - 2021 Member, Oversight Committee, UK Coronavirus Immunology Consortium (CIC)
  
• 2020 - 2021, Member, Expert group Covid-19, Royal Swedish Academy of Sciences
  
• 2020 Member, COVID-19 Resource Group, Karolinska Institutet
  
• 2021 Covid-19 Vaccine Research Coordinator, Karolinska Institutet
  
• 2022 - 2024 Member, Evaluation group Sven Gard Prize in viral research
  
• 2022 Member, The Sjöberg Prize Committee, Royal Swedish Academy of Sciences
  
• 2022 Chairman Steering group, KI Center for Health Crises

Evaluator, reviewer or other advisory assignments for national and international research organizations (academic)

1994-, reviewer Swedish Research Council, reviewer/study section and senior investigator awards Swedish Cancer Society, reviewer Swedish Children’s Cancer Foundation, reviewer Norwegian Research Council, reviewer/study section Finnish Academy, reviewer Wellcome Trust Foundation, reviewer German-Israel Science Foundation, reviewer Netherlands Cancer Society, reviewer Wiessenschaftsfond Austria, reviewer National Institute of Health USA, reviewer/study section Singapore Immunology Network (SIgN), reviewer National University of Singapore, reviewer Novo Nordisk A/S, reviewer Dutch Spinoza Price, reviewer Research Grants Council (RGC) of Hong Kong, evaluator Leibniz-Gemeinschaft Berlin, reviewer/study section Institute for Basic Science (IBS) Korea, advisor/reviewer German Federal Ministry of Education and Research, reviewer The Netherlands Organization of Scientific Research (NOW/ZonMw), reviewer Israel Science Foundation (ISF), reviewer CNRS and INSERM, evaluator Poland – US Science Award for the Foundation for Polish Science (FNP) and the American Association for the Advancement of Science (AAAS), University of Lund

Academic advisory roles

• 2007 - 2008, Scientific Advisory Board, Umeå Center for Microbial Research
  
• 2011 Advisory Board, Hannover Biomedical Research School, MHH
  
• 2014 - 2015, Advisory Board, Vaccine Gene Therapy Institute (VGTI), Port St Lucie, FL, USA
  
• 2016 Scientific Advisory Board, Mucosal Infection & Inflammation Center, Linköping Univ
  
• 2016 - 2018, External Scientific Advisor, VR Framework program, Stockholm Univ
  
• 2017 External Advisory Board, “MATURE-NK”, EU Marie Curie Consortial Grant
  
• 2017 Advisory Board, Faculty of Medicine, Aarhus Universitet, Aarhus, Denmark
  
• 2017 - 2019, Foreign National Consultant, Nova Southeastern University, Ft Lauderdale, FL
  
• 2022 Member Scientific Advisory Group, International Vaccine Institute (IVI)

Corporate board membership, advisory roles and entrepreneurial activities

• 2000 - 2006 Scientific Advisory Board (SAB), Accuro Immunology AB
  
• 2001 - 2004 Board member, Hansa Medical AB
  
• 2012 Co-founder, Cell Protect Nordic Pharmaceutical AB (from 2020 XNK Therapeutics AB)
  
• 2013 - 2016 Industrial collaborations set up between KI and AstraZeneca (100 million USD), Ferring, Novo Nordisk, Merck/MSD, Johnson&Johnson (as Dean of Research)
  
• 2016 Co-founder and CMO, Vycellix Inc
  
• 2016 Board member, Vycellix Inc
  
• 2016-2021 Chairman, Scientific Advisory Board (SAB), XNK Therapeutics AB
  
• 2017-2018 Scientific Advisory Board (SAB), Hope Bio-Sciences Inc
  
• 2018 Scientific Advisory Board (SAB), Hope/TRIGR Therapeutics
  
• 2017 Collaborator, FATE Therapeutics Inc
  
• 2018 Board member, XNK Therapeutics AB
  
• 2018 - 2021 Scientific Advisory Board (SAB), Morphogenesis Inc
  
• 2020 Scientific Advisor, Swedish Orphan Biovitrum (SOBI)
  
• 2021 Co-founder and CMO, VyGen-Bio Inc
  
• 2021 Scientific Advisory Board (SAB), Coeptis Pharmaceuticals, Inc.
  
• 2022 Co-Founder and Board Member, Vycellix Sweden AB